» Articles » PMID: 3966997

A Randomised Prospective Study on Treatment of Central Retinal Vein Occlusion by Isovolaemic Haemodilution and Photocoagulation

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1985 Feb 1
PMID 3966997
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty eight patients with ischaemic and non-ischaemic central retinal vein occlusion were evaluated for the effect of isovolaemic haemodilution. They were allocated at random to a haemodilution group (19 patients, panretinal photocoagulation and isovolaemic haemodilution) and a control group (19 patients, panretinal photocoagulation). Haematocrit was lowered in steps to 30 to 35% in the haemodilution group by repeated exchanges of whole blood for plasma and dextran (MW 40 000) and kept at this level for a period of six weeks. The haemodilution did not lead to serious complications. Three months after starting the treatment eight of 19 patients with haemodilution showed a better visual acuity, whereas only one of 19 control patients had improved. Seven of 17 patients with haemodilution, but only one of 17 control patients, retained a better visual acuity after one year. In the haemodilution group there were fewer patients with macular fibrosis and more with only minor foveal changes. The haemodilution seems to be more effective in patients with ischaemic than with non-ischaemic central retinal vein occlusion. It is concluded that isovolaemic haemodilution improves the visual outcome of patients with central retinal vein occlusion, probably mediated by enhanced retinal blood flow.

Citing Articles

Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.

Chiquet C, Dupuy C, Bron A, Aptel F, Straub M, Isaico R Graefes Arch Clin Exp Ophthalmol. 2015; 253(12):2095-102.

PMID: 25673251 DOI: 10.1007/s00417-015-2947-9.


[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].

Heiligenhaus A, Bertram B, Heinz C, Krause L, Pleyer U, Roider J Ophthalmologe. 2014; 111(8):740-8.

PMID: 25118844 DOI: 10.1007/s00347-014-3130-0.


Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.

Glacet-Bernard A, Atassi M, Fardeau C, Romanet J, Tonini M, Conrath J Graefes Arch Clin Exp Ophthalmol. 2010; 249(4):505-12.

PMID: 20953877 DOI: 10.1007/s00417-010-1532-5.


Retinal vascular occlusions: an interdisciplinary challenge.

Mirshahi A, Feltgen N, Hansen L, Hattenbach L Dtsch Arztebl Int. 2009; 105(26):474-9.

PMID: 19626196 PMC: 2696914. DOI: 10.3238/arztebl.2008.0474.


Bevacizumab in retinal vein occlusion-results of a prospective case series.

Stahl A, Agostini H, Hansen L, Feltgen N Graefes Arch Clin Exp Ophthalmol. 2007; 245(10):1429-36.

PMID: 17356824 DOI: 10.1007/s00417-007-0569-6.


References
1.
Sedney S . Photocoagulation in retinal vein occlusion. Doc Ophthalmol. 1976; 40(1):1-241. DOI: 10.1007/BF00155051. View

2.
Hayreh S . So-called "central retinal vein occlusion". I. Pathogenesis, terminology, clinical features. Ophthalmologica. 1976; 172(1):1-13. DOI: 10.1159/000307579. View

3.
Hayreh S . So-called "central retinal vein occlusion". II. Venous stasis retinopathy. Ophthalmologica. 1976; 172(1):14-37. DOI: 10.1159/000307580. View

4.
Kohner E, Pettit J, Hamilton A, Bulpitt C, Dollery C . Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J. 1976; 1(6009):550-3. PMC: 1639322. DOI: 10.1136/bmj.1.6009.550. View

5.
Ring C, Pearson T, Sanders M, WETHERLEY-MEIN G . Viscosity and retinal vein thrombosis. Br J Ophthalmol. 1976; 60(6):397-410. PMC: 1017519. DOI: 10.1136/bjo.60.6.397. View